Clinical applications and perspectives of circulating tumor DNA in gastric cancer
Abstract Gastric cancer remains a leading cause of cancer-related death worldwide, largely due to inadequate screening methods, late diagnosis, and limited treatment options. Liquid biopsy has emerged as a promising non-invasive approach for cancer screening and prognosis by detecting circulating tu...
Main Authors: | Jing-Han Li, Dan-Ying Zhang, Ji-Min Zhu, Ling Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03209-4 |
Similar Items
-
The progress and future prospects of the application of circulating tumor DNA in the diagnosis and treatment of gastric cancer
by: SUN Chongyuan, ZHAO Dongbing
Published: (2023-08-01) -
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives
by: Giulia Grizzi, et al.
Published: (2023-05-01) -
Cell-free circulating tumor DNA in cancer
by: Zhen Qin, et al.
Published: (2016-04-01) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
DNA nanotechnology in tumor liquid biopsy: Enrichment and determination of circulating biomarkers
by: Yitong Zhu, et al.
Published: (2024-01-01)